First Pharma OÜRegistered
Key figures
4 875 857 €−13,1%
Revenue 2025
+7,8%
Average annual growth 2019–2025
Ratios
20253,1%
Profit margin
4,8%
EBITDA margin
23,6%
Equity ratio
1,3×
Current ratio
65,8%
Return on equity
3304 €
Average gross salary
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 2 243 851 € | 9 | 48 953 € |
| Q1 2026 | 2 210 394 € | 9 | 48 886 € |
| Q4 2025 | 2 033 049 € | 8 | 45 852 € |
| Q3 2025 | 2 103 073 € | 7 | 50 718 € |
| Q2 2025 | 1 863 661 € | 8 | 55 070 € |
| Q1 2025 | 1 932 964 € | 7 | 53 887 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Dividends
calculated2025
Distributed as dividends 152 000 € (67% of distributable profit).
History
2025152 000 €
2024252 786 €
2023177 850 €
2022144 530 €
2021123 432 €
202094 186 €
Previous year's retained earnings + previous year's profit − current retained earnings.
Summary of financial statements2019–2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||
| Total current assets | 464 818 | 618 637 | 655 311 | 794 476 | 886 964 | 837 778 | 939 893 |
| Total non-current assets | — | 8680 | 52 468 | 40 248 | 28 028 | 15 808 | 17 675 |
| Total assets | 464 818 | 627 317 | 707 779 | 834 724 | 914 992 | 853 586 | 957 568 |
| Balance sheet — liabilities and equity | |||||||
| Current liabilities | 360 053 | 469 448 | 528 680 | 645 852 | 658 943 | 624 096 | 731 315 |
| Non-current liabilities | 0 | 0 | 31 721 | 8174 | 0 | — | — |
| Total liabilities | 360 053 | 469 448 | 560 401 | 654 026 | 658 943 | 624 096 | 731 315 |
| Share capital | 2589 | 2589 | 2589 | 2589 | 2589 | 2589 | 2589 |
| Retained earnings of previous periods | 72 069 | 7731 | 31 589 | 0 | 0 | 415 | 74 642 |
| Profit for the year | 29 848 | 147 290 | 112 941 | 177 850 | 253 201 | 226 227 | 148 763 |
| Reserves and other equity | 259 | 259 | 259 | 259 | 259 | 259 | 259 |
| Total equity | 104 765 | 157 869 | 147 378 | 180 698 | 256 049 | 229 490 | 226 253 |
| Income statement | |||||||
| Sales revenue | 3 107 916 | 4 595 381 | 4 239 209 | 5 138 231 | 5 240 425 | 5 609 729 | 4 875 857 |
| Operating profit | 53 692 | 185 303 | 151 296 | 231 293 | 314 371 | 308 096 | 227 021 |
| EBITDA | — | — | 156 388 | 243 513 | 326 591 | 320 316 | 234 149 |
| Profit before income tax | 37 733 | 169 265 | 133 154 | 213 651 | 286 542 | 270 021 | 191 635 |
| Profit for the reporting year | 29 848 | 147 290 | 112 941 | 177 850 | 253 201 | 226 227 | 148 763 |
| Labour costs | 174 913 | 265 198 | 244 987 | 270 007 | 290 771 | 448 498 | 458 549 |
| Depreciation of non-current assets | — | — | 5092 | 12 220 | 12 220 | 12 220 | 7128 |
| Other indicators | |||||||
| Employees | 5 | 6 | 7 | 7 | 7 | 9 | 9 |
| Calculated dividend | — | 94 186 | 123 432 | 144 530 | 177 850 | 252 786 | 152 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
CompanyPersonShareholderOther roleAdditional link
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Related companies
Same activity — Ravimite ja muude apteegikaupade hulgimüük